Small Intestine Related Diseases
Conditions
Interventions
ciprofol group:ciprofol 0.2mg/kg
Propofol group:Propofol 1.5mg/kg
Sponsors
900th Hospital of the United Logistics Force
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. patients who meet the indications for small boweloscopy; 2. Age >=18 and <=80 years; 3. American Society of Anaesthesiologists grade I to III; 4. Willing to sign the informed consent and strictly comply with the study protocol.
Exclusion criteria
Exclusion criteria: 1.Allergy to propofol, cypropofol, fentanyl and its antidotes, eggs or soya; 2.Combined major organ dysfunction, various acute conditions, systemic infectious diseases; 3.Combination of severe cardio-cerebral and pulmonary diseases; 4.Combined with mental diseases and cognitive disorders; 5.Presence of contraindications to anaesthesia and surgery; 6.Long-term use of sedative drugs; 7.Pregnant and lactating women; 8.Participation in any pharmacological clinical trials within the last 3 months; 9.Subjects who, in the opinion of the investigator, have any other factors that make participation in this clinical study inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of enteroscope; | — |
Secondary
| Measure | Time frame |
|---|---|
| Induction time;Insertion time;Examination time;Awakening time;Orientation recovery time;Time out of the post-anaesthetic care unit;blood pressure;heart rate ;respiratory rate ;saturation of peripheral oxygen ;modified observer's assessment of alertness or sedation;Intraoperative adverse events;postoperative adverse reaction;Satisfaction Assessment; | — |
Countries
China
Contacts
Public ContactHe Xiaojian
Department of Gastroenterology, 900th Hospital of the United Logistics Force
Outcome results
None listed